HARTE-HANKS INC (HHS)
US4161962026 - Common Stock
Overall HHS gets a fundamental rating of 4 out of 10. We evaluated HHS against 92 industry peers in the Media industry. HHS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HHS is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
HHS had positive earnings in the past year.
HHS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HHS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: HHS reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of HHS (-26.78%) is worse than 85.71% of its industry peers.
The Return On Equity of HHS (-142.58%) is worse than 82.42% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.06%, HHS belongs to the top of the industry, outperforming 90.11% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HHS is significantly above the industry average of 7.64%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.78% | ||
| ROE | -142.58% | ||
| ROIC | 10.06% |
ROA(3y)13.3%
ROA(5y)2.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.02%
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 4.99%, HHS is in line with its industry, outperforming 49.45% of the companies in the same industry.
Looking at the Gross Margin, with a value of 18.65%, HHS is doing worse than 80.22% of the companies in the same industry.
In the last couple of years the Gross Margin of HHS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.99% | ||
| PM (TTM) | N/A | ||
| GM | 18.65% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.49%
GM growth 5Y19.74%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HHS is still creating some value.
Compared to 1 year ago, HHS has less shares outstanding
HHS has more shares outstanding than it did 5 years ago.
HHS has a better debt/assets ratio than last year.
2.2 Solvency
HHS has an Altman-Z score of 12.89. This indicates that HHS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.89, HHS belongs to the top of the industry, outperforming 98.90% of the companies in the same industry.
HHS has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
HHS has a better Debt to Equity ratio (0.02) than 82.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 12.89 |
ROIC/WACC1.06
WACC9.49%
2.3 Liquidity
HHS has a Current Ratio of 1.51. This is a normal value and indicates that HHS is financially healthy and should not expect problems in meeting its short term obligations.
HHS has a Current ratio of 1.51. This is comparable to the rest of the industry: HHS outperforms 53.85% of its industry peers.
HHS has a Quick Ratio of 1.51. This is a normal value and indicates that HHS is financially healthy and should not expect problems in meeting its short term obligations.
HHS has a Quick ratio (1.51) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 1.51 |
3. Growth
3.1 Past
HHS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.55%.
The Revenue has decreased by -7.18% in the past year.
Measured over the past years, HHS shows a decrease in Revenue. The Revenue has been decreasing by -7.62% on average per year.
EPS 1Y (TTM)-26.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-7.18%
Revenue growth 3Y2.68%
Revenue growth 5Y-7.62%
Sales Q2Q%1.08%
3.2 Future
HHS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.18% yearly.
HHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.68% yearly.
EPS Next Y-729.87%
EPS Next 2Y40.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.64%
Revenue Next 2Y1.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 2.91 indicates a rather cheap valuation of HHS.
Compared to the rest of the industry, the Price/Earnings ratio of HHS indicates a rather cheap valuation: HHS is cheaper than 96.70% of the companies listed in the same industry.
HHS is valuated cheaply when we compare the Price/Earnings ratio to 29.20, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 5.44, the valuation of HHS can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HHS indicates a rather cheap valuation: HHS is cheaper than 96.70% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of HHS to the average of the S&P500 Index (24.00), we can say HHS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.91 | ||
| Fwd PE | 5.44 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HHS is valued cheaper than 96.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.27 |
4.3 Compensation for Growth
A more expensive valuation may be justified as HHS's earnings are expected to grow with 40.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.18%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for HHS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HARTE-HANKS INC
NASDAQ:HHS (11/22/2024, 8:00:00 PM)
5.875
+0.22 (+3.98%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap42.83M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.91 | ||
| Fwd PE | 5.44 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.78% | ||
| ROE | -142.58% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 4.99% | ||
| PM (TTM) | N/A | ||
| GM | 18.65% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.51 | ||
| Quick Ratio | 1.51 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-26.55%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-729.87%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.18%
Revenue growth 3Y2.68%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y